Dermatol. praxi. 2009;3(3):109-118 [Klin Farmakol Farm. 2008;22(2):72-80]
Superficial fungal infections are common, particularly dermatophytoses, onychomycoses, and vulvovaginal Candida infections. Most of
these mycoses are treated with topical antimycotic drugs unless the infection involves an extensive area or is resistant to initial therapy.
The use of griseofulvin in dermatology is limited to a few indications (tinea capitis in children), ketoconazole is replaced by other triazole
drugs with a better pharmacological profile (no risk of idiopathic hepatitis) in most indications. Onychomycosis – one of the most difficultto-
treat dermatomycosis largely requires systemic therapy with terbinafine or itraconazole which can be combined with topical drugs
such as amorolfine and ciclopirox olamine. Fluconazole is a drug of choice in the majority of cases of oropharyngeal and vulvovaginal
infections caused by Candida albicans and other susceptible yeasts. The therapeutic regimen of refractory mucosal mycoses should be
modified in terms of dosage, duration of therapy, and choice of an adequate antifungal drug according to etiological agents and/or immune
status of the patient. The goal of this review is to provide an overview of currently available therapeutic options for the treatment
of common skin and mucosal fungal infections.
Published: June 1, 2009 Show citation